Details of the Drug

General Information of Drug (ID: DMCVCZ6)

Drug Name

LX-6171

Synonyms

CNS therapeutics, Lexicon; LG617 program, Lexicon

Indication

Disease Entry	ICD 11	Status	REF
Neurological disorder	6B60	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H20ClN3O
Canonical SMILES: C1CN(CCC1C(=O)C2=CC=C(C=C2)C3=CC(=CC=C3)Cl)C4=NC=CC=N4
InChI: 1S/C22H20ClN3O/c23-20-4-1-3-19(15-20)16-5-7-17(8-6-16)21(27)18-9-13-26(14-10-18)22-24-11-2-12-25-22/h1-8,11-12,15,18H,9-10,13-14H2
InChIKey: VHTIWIZIPOXSNP-UHFFFAOYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00691808) Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment. U.S. National Institutes of Health.